Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in Advanced Hepatocellular Carcinoma and Cirrhosis
NCT06007846Phase 3Recruiting
- Sponsor
- Inova Health System
- Start
- Jul 2023
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in hepatocellular carcinoma (HCC), sponsored by Inova Health System. Started Jul 2023; status: recruiting.
02
Drugs
memantine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT06007846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06007846.